LTS Lohmann Therapie-Systeme AG

2 Decision Makers · 4 Verified Contacts & Email Format

📍 Andernach, Rheinland-Pfalz, GermanyBiotechnology🗓 Est. 1984👥 1001–5000 employees

About LTS Lohmann Therapie-Systeme AG

LTS Lohmann Therapie-Systeme AG is the market leader in trans dermal therapeutic systems and oral drug films.

Email Format

{first_name}.{last_name}@ltslohmann.de — 100.0%

sarah.smith@ltslohmann.de

Leadership & Decision Makers

Contact details of 2 LTS Lohmann Therapie-Systeme AG decision makers

Wolfgang Hartwig

Chairman of the Executive Board

Dave Doles

President and Chief Executive Officer

Team & Specialists

Contact details of 2 LTS Lohmann Therapie-Systeme AG team members

Alan Gregory

Production Manager LinkedIn
  • Work email

    a**********y@ltslohmann.de

Joachim Hartmann

  • Work email

    j**************n@ltslohmann.de

General Emails

General company emails, e.g. customer support lines

    info@ltslohmann.de

    General Inquiries

    ltsgroup@ltslohmann.de

    Unclassified inbox

Similar Companies like LTS Lohmann Therapie-Systeme AG

KBI Biopharma

kbibiopharma.com
Pharmaceuticals · Durham, NC · Est. 1996 · 1001–5000 employees · $500M–$1B

HQ: Durham, NC

Moderna

modernatx.com
Biotechnology · Cambridge, MA · Est. 2010 · 1001–5000 employees

HQ: Cambridge, MA

Seagen

seagen.com
Biotechnology · Bothell, Washington, United States · Est. 1998 · 1001–5000 employees · $500M–$1B

HQ: Bothell, Washington, United States

Biotechnology · Boston, MA · Est. 1989 · 1001–5000 employees · $500M–$1B

HQ: Boston, MA

Fulgent Therapeutics

fulgentgenetics.com
Biotechnology · Temple City, California, United States · Est. 2011 · 1001–5000 employees

HQ: Temple City, California, United States

Explore similar firms in the Biotechnology sector

Company Info

Last updated: 27/07/2025

+49 2632 990

Andernach, Rheinland-Pfalz, Germany

Business Type: Private
Employees: 1001-5000
Rounds: Grant
Founded Date: 1984
Company Type: For Profit
Operating Status: Active
Last Funding Type: Grant
Phone Number: +49 2632 990
Last Investment Activity: Dec 19, 2023
Investments Activity: Dec 19, 2023 Dec 6, 2023 Jun 8, 2023

Our service is undergoing beta testing, and you can get all the information that is closed on this page for free by registering. You will not need to provide your credit/debit card details.